Magenta Therapeutics

Magenta Therapeutics

Magenta Therapeutics

magenta is harnessing stem cell biology to make transplants safer and more effective for patients with immune and blood-based diseases our site
Founded
2016
Raised
$250.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$100,000,000
IPO - 2018
$52,000,000
Venture capital (Series C) - 2018
Access Industries EcoR1 Capital Casdin Capital +3
Team Size
10+
Employees
the home of AI info

Comparing of Minerva Neurosciences Inc. (NERV) and Magenta Therapeutics Inc. (NASDAQ:MGTA)

$100,000,000 IPO
PE HUB

Magenta Therapeutics starts trading on the NASDAQ

Stock markets Health
$52,000,000 Venture capital (Series C)
Venture Funding News , PE HUB

Magenta Therapeutics Secures $52M in Series C

FinSMEs

Magenta Therapeutics Secures $52M in Series C Financing

Funding Health
$50,000,000 Venture capital (Series B)
PE HUB , Xconomy

Magenta Therapeutics takes in $50 mln Series B

Funding Messaging
$48,500,000 Venture capital (Series A)
FinSMEs

Magenta Therapeutics Completes $48.5M Series A Financing

Science Health Education